The European Innovative Medicines Initiative: Progress to Date

Pharmaceutical Medicine
Jean-Emmanuel FaureLine Matthiessen

Abstract

The Innovative Medicines Initiative is a public-private partnership between the European Union and the pharmaceuticals industry that was established in 2008, with an overall budget of €5.3 billion from 2008 until 2024. The objective of the initiative is to boost pharmaceutical innovation in Europe and speed up the development of innovative medicines, vaccines and medical technologies, in particular in areas with high unmet needs. This article discusses the objectives of the initiative, its governance and main results and impact. The initiative has proved to be a unique platform for multi-stakeholder collaborations across Europe. It has contributed to the acceleration of the development process for medicines, from drug discovery to clinical development. The initiative has made important steps towards accessing and using real-world evidence for pharmaceutical research and development, and for healthcare decision-making. Several projects have contributed to a better understanding of the causes of diseases, and some are already delivering results, such as a vaccine against Ebola virus. The initiative has also significantly contributed to building capacity and resources for open use by the broader research and innovation community.

References

May 3, 2011·Nature Reviews. Drug Discovery·Michel Goldman
Jun 8, 2012·The Biochemical Journal·Alexandros PoulopoulosNils Brose
Aug 13, 2013·Brain : a Journal of Neurology·Meng-Chuan LaiSimon Baron-Cohen
Sep 11, 2014·Drug Discovery Today·Jérémy BesnardAndrew D Pannifer
Jan 31, 2015·Nature Reviews. Drug Discovery·Martin Hofmann-ApitiusDuncan McHale
Aug 21, 2015·Nature Reviews. Neuroscience·Thomas Bourgeron
Sep 12, 2015·The Lancet. Psychiatry·Eva LothUNKNOWN EU-AIMS consortium
Sep 26, 2015·The European Respiratory Journal·Louise FlemingUNKNOWN U-BIOPRED Study Group
Oct 20, 2015·The Lancet. Respiratory Medicine·UNKNOWN Lancet Respiratory Medicine
Dec 8, 2016·American Journal of Respiratory and Critical Care Medicine·Jeannette BiglerUNKNOWN U-BIOPRED Study Group ‖
Mar 16, 2017·JAMA : the Journal of the American Medical Association·Rebecca L WinslowMatthew D Snape
May 28, 2017·Journal of Clinical Epidemiology·Mira G P ZuidgeestUNKNOWN GetReal Work Package 3
Jun 27, 2017·Molecular Autism·Tony CharmanJan K Buitelaar
Sep 1, 2017·Journal of Comparative Effectiveness Research·Amr MakadyWim Goettsch
Sep 29, 2017·The European Respiratory Journal·Pieter-Paul HekkingUNKNOWN U-BIOPRED Study Group
Oct 14, 2017·Nature Reviews. Drug Discovery·Ferran SanzIsmael Zamora
Apr 24, 2018·Molecular Autism·Johan IsakssonUNKNOWN EU-AIMS LEAP group
Dec 13, 2018·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Jason ChenJoseph Rosenthal

❮ Previous
Next ❯

Citations

Apr 7, 2020·Expert Review of Clinical Immunology·Vinod Chandran
Jul 29, 2020·Therapeutic Innovation & Regulatory Science·Belkis Romeu, Rafael Perez Cristiá
Dec 19, 2019·Frontiers in Medicine·Hugh Laverty, Pierre Meulien

❮ Previous
Next ❯

Methods Mentioned

BETA
imaging techniques

Software Mentioned

PRO
SMART
COMBACTE
Active
NET
CNS
ADAPT
IMI2
Mofina
AETIONOMY

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
Eurosurveillance editorial team
European Journal of Immunology
Michel GoldmanMaria-Teresa De Magistris
© 2022 Meta ULC. All rights reserved